Related references
Note: Only part of the references are listed.Early mortality in patients starting dialysis appears to go unregistered
Robert N. Foley et al.
KIDNEY INTERNATIONAL (2014)
Altitude and the risk of cardiovascular events in incident US dialysis patients
Wolfgang C. Winkelmayer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
William G. Couser et al.
KIDNEY INTERNATIONAL (2011)
Altitude and All-Cause Mortality in Incident Dialysis Patients
Wolfgang C. Winkelmayer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The effect of altitude on dosing and response to erythropoietin in ESRD
M. Alan Brookhart et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes
Lynda A. Szczech et al.
KIDNEY INTERNATIONAL (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
